Loring Wolcott & Coolidge Fiduciary Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-23,845
Closed -$2.37M 746
2019
Q3
$2.37M Sell
23,845
-17,352
-42% -$1.65M 0.03% 107
2019
Q2
$3.81M Sell
41,197
-265,716
-87% -$25.2M 0.06% 92
2019
Q1
$29M Sell
306,913
-664,850
-68% -$58.1M 0.44% 51
2018
Q4
$62.3M Sell
971,763
-231,231
-19% -$17.1M 1.13% 30
2018
Q3
$108M Sell
1,202,994
-15,241
-1% -$1.35M 1.71% 20
2018
Q2
$96.8M Sell
1,218,235
-1,316
-0.1% -$109K 1.68% 19
2018
Q1
$109M Buy
1,219,551
+89,509
+8% +$8.59M 1.98% 17
2017
Q4
$118M Buy
1,130,042
+77,016
+7% +$8.69M 2.17% 16
2017
Q3
$154M Buy
1,053,026
+35,846
+4% +$4.88M 2.97% 10
2017
Q2
$138M Buy
1,017,180
+73,107
+8% +$8.96M 2.74% 10
2017
Q1
$117M Buy
944,073
+49,400
+6% +$5.91M 2.46% 11
2016
Q4
$104M Buy
894,673
+57,631
+7% +$6.42M 2.31% 12
2016
Q3
$87.5M Buy
837,042
+51,173
+7% +$5.54M 2% 16
2016
Q2
$77.5M Buy
785,869
+29,583
+4% +$3.06M 1.78% 20
2016
Q1
$75.7M Buy
756,286
+134,634
+22% +$13.9M 1.79% 21
2015
Q4
$74.4M Buy
621,652
+36,882
+6% +$4.27M 1.84% 20
2015
Q3
$67.7M Hold
584,770
1.73% 21
2015
Q2
$67.7M Sell
584,770
-1,332
-0.2% -$152K 1.73% 21
2015
Q1
$67.6M Buy
586,102
+22,806
+4% +$2.73M 1.7% 22
2014
Q4
$63M Sell
563,296
-1,061
-0.2% -$112K 1.61% 23
2014
Q3
$53.5M Buy
564,357
+8,647
+2% +$780K 1.45% 24
2014
Q2
$47.7M Buy
555,710
+262,202
+89% +$19.9M 1.29% 27
2014
Q1
$20.5M Buy
293,508
+196,880
+204% +$15.6M 0.56% 48
2013
Q4
$8.16M Buy
96,628
+1,404
+1% +$111K 0.23% 72
2013
Q3
$7.34M Buy
95,224
+5,660
+6% +$397K 0.22% 76
2013
Q2
$5.24M Buy
+89,564
New +$5.39M 0.16% 93

Other funds holding CELG

Loring Wolcott & Coolidge Fiduciary Advisors's CELG Position: Q4 2019 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 23,845 shares — an estimated $2.37M sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $154M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 23,845 Celgene Corp shares in Q4 2019, an estimated $2.37M.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Celgene Corp position peaked at $154M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2019, filed 22 Jan 2020.